메뉴 건너뛰기




Volumn 27, Issue , 2014, Pages 53-57

Metabolomics technology and their application to the study of the viral infection

Author keywords

Metabolism; Metabolites; Metabolomics; Multivariate statistical analysis; Viral infection.

Indexed keywords

AMINO ACID; ANTIRETROVIRUS AGENT; CARBOHYDRATE; KETONE BODY; LIPID; NUCLEOTIDE; TAURINE;

EID: 84911910753     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2014.955963     Document Type: Review
Times cited : (18)

References (29)
  • 1
    • 0032694577 scopus 로고    scopus 로고
    • 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data
    • Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999;29:1181-9.
    • (1999) Xenobiotica , vol.29 , pp. 1181-1189
    • Nicholson, J.K.1    Lindon, J.C.2    Holmes, E.3
  • 2
    • 0036007687 scopus 로고    scopus 로고
    • Metabolomics-The link between genotypes and phenotypes
    • Fiehn O. Metabolomics-the link between genotypes and phenotypes. Plant Mol Biol 2002;48:155-71.
    • (2002) Plant Mol Biol , vol.48 , pp. 155-171
    • Fiehn, O.1
  • 3
    • 84884958498 scopus 로고    scopus 로고
    • The role of metabolomics in neonatal and pediatric laboratory medicine
    • Mussap M, Antonucci R, Noto A. The role of metabolomics in neonatal and pediatric laboratory medicine. Clin Chim Acta 2013; 426:127-38.
    • (2013) Clin Chim Acta , vol.426 , pp. 127-138
    • Mussap, M.1    Antonucci, R.2    Noto, A.3
  • 4
    • 70149092076 scopus 로고    scopus 로고
    • Analytical and statistical approaches to metabolomics research
    • Issaq HJ, Van QN, Waybright TJ. Analytical and statistical approaches to metabolomics research. J Sep Sci 2009;32:2183-99.
    • (2009) J Sep Sci , vol.32 , pp. 2183-2199
    • Issaq, H.J.1    Van Qn Waybright, T.J.2
  • 5
    • 84911878018 scopus 로고    scopus 로고
    • [last accessed 10 Jul 2014]
    • World Health Statistics; 2013. Available from http://www.who.int/en/[last accessed 10 Jul 2014].
    • (2013)
  • 6
    • 79960284362 scopus 로고    scopus 로고
    • Viruses and metabolism: Alterations of glucose and glutamine metabolism mediated by human cytomegalovirus
    • Yu Y, Clippinger AJ, Pierciey Jr FJ, Alwine JC. Viruses and metabolism: alterations of glucose and glutamine metabolism mediated by human cytomegalovirus. Adv Virus Res. 2011;80: 49-67.
    • (2011) Adv Virus Res. , vol.80 , pp. 49-67
    • Yu, Y.1    Clippinger, A.J.2    Pierciey, F.J.3    Alwine, J.C.4
  • 8
    • 9644259300 scopus 로고    scopus 로고
    • Human cytomegalovirus: Clinical aspects, immune regulation, and emerging treatments
    • Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 2004;4:725-38.
    • (2004) Lancet Infect Dis , vol.4 , pp. 725-738
    • Gandhi, M.K.1    Khanna, R.2
  • 9
    • 39049157379 scopus 로고    scopus 로고
    • New advances in the diagnosis of congenital cytomegalovirus infection
    • Lazzarotto T, Guerra B, Lanari M, et al. New advances in the diagnosis of congenital cytomegalovirus infection. J Clin Virol 2008;41:192-7.
    • (2008) J Clin Virol , vol.41 , pp. 192-197
    • Lazzarotto, T.1    Guerra, B.2    Lanari, M.3
  • 10
    • 80051876843 scopus 로고    scopus 로고
    • Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy
    • Lazzarotto T, Guerra B, Gabrielli L, et al. Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clin Microbiol Infect 2011;17:1285-93.
    • (2011) Clin Microbiol Infect , vol.17 , pp. 1285-1293
    • Lazzarotto, T.1    Guerra, B.2    Gabrielli, L.3
  • 11
    • 33644845269 scopus 로고    scopus 로고
    • Neonatal cytomegalo-virus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns
    • Lanari M, Lazzarotto T, Venturi V, et al. Neonatal cytomegalo-virus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 2006; 117:e76-83.
    • (2006) Pediatrics , vol.117 , pp. e76-83
    • Lanari, M.1    Lazzarotto, T.2    Venturi, V.3
  • 12
    • 84879808219 scopus 로고    scopus 로고
    • Urinary metabolomics in newborns infected by human cytomegalovirus: A preliminary investigation
    • 89S1
    • Fanos V, Locci E, Noto A, et al. Urinary metabolomics in newborns infected by human cytomegalovirus: a preliminary investigation. Early Human Develop 2013;89S1:S58-61.
    • (2013) Early Human Develop , pp. S58-61
    • Fanos, V.1    Locci, E.2    Noto, A.3
  • 13
    • 33845970245 scopus 로고    scopus 로고
    • Dynamics of the cellular metabolome during human cytomegalovirus infection
    • Munger J, Bajad SU, Coller HA, et al. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog 2006;2:e132.
    • (2006) PLoS Pathog , vol.2 , pp. e132
    • Munger, J.1    Bajad, S.U.2    Coller, H.A.3
  • 14
    • 33646250428 scopus 로고    scopus 로고
    • The natural history of hepatitis C virus (HCV) infection
    • Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 2006;3:47-52.
    • (2006) Int J Med Sci , vol.3 , pp. 47-52
    • Chen, S.L.1    Morgan, T.R.2
  • 15
    • 0642345166 scopus 로고    scopus 로고
    • The epidemiology and natural history of hepatitis C virus infection
    • Zein NN. The epidemiology and natural history of hepatitis C virus infection. Cleve Clin J Med 2003;70:S2-6.
    • (2003) Cleve Clin J Med , vol.70 , pp. S2-6
    • Zein, N.N.1
  • 16
    • 84866177809 scopus 로고    scopus 로고
    • Quantifying the diversification of hepatitis C virus (HCV) during primary infection: Estimates of the in vivo mutation rate
    • Ribeiro RM, Li H, Wang S, et al. Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate. PLoS Pathog 2012;8:e1002881.
    • (2012) PLoS Pathog , vol.8 , pp. e1002881
    • Ribeiro, R.M.1    Li, H.2    Wang, S.3
  • 17
    • 0033373404 scopus 로고    scopus 로고
    • Hepatitis C virus genotypes and quasispecies
    • Davis GL. Hepatitis C virus genotypes and quasispecies. Am J Med 1999;107:21S-5S.
    • (1999) Am J Med , vol.107 , pp. 21S-5S
    • Davis, G.L.1
  • 18
    • 7444256169 scopus 로고    scopus 로고
    • Genetic diversity and evolution of hepatitis C virus-15 years on
    • Simmods P. Genetic diversity and evolution of hepatitis C virus-15 years on. J Gen Virol 2004;85:3173-88.
    • (2004) J Gen Virol , vol.85 , pp. 3173-3188
    • Simmods, P.1
  • 19
    • 80051643187 scopus 로고    scopus 로고
    • Metabolomic profile of hepatitis C virus-infected hepatocytes
    • Roe B, Kensicki E, Mohney R, Hall WW. Metabolomic profile of hepatitis C virus-infected hepatocytes. PLoS One 2011; 6:e23641.
    • (2011) PLoS One , vol.6 , pp. e23641
    • Roe, B.1    Kensicki, E.2    Mohney, R.3    Hall, W.W.4
  • 20
    • 84874642175 scopus 로고    scopus 로고
    • Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews
    • Sun H, Zhang A, Yan G, et al. Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews. Mol Cell Proteomics 2013;12:710-19.
    • (2013) Mol Cell Proteomics , vol.12 , pp. 710-719
    • Sun, H.1    Zhang, A.2    Yan, G.3
  • 21
    • 79251490096 scopus 로고    scopus 로고
    • Peginterferon plus adefovir versus either drug alone for hepatitis delta
    • Wedemeyer H, Yurdaydin C, Dalekos GN, et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med 2011;364:322-31.
    • (2011) N Engl J Med , vol.364 , pp. 322-331
    • Wedemeyer, H.1    Yurdaydin, C.2    Dalekos, G.N.3
  • 22
    • 84880440812 scopus 로고    scopus 로고
    • Association of early age at establishment of chronic hepatitis B infection with persistent viral replication, liver cirrhosis and hepato-cellular carcinoma: A systematic review
    • Shimakawa Y, Yan HJ, Tsuchiya N, et al. Association of early age at establishment of chronic hepatitis B infection with persistent viral replication, liver cirrhosis and hepato-cellular carcinoma: a systematic review. PLoS One 2013;8: e69430.
    • (2013) PLoS One , vol.8 , pp. e69430
    • Shimakawa, Y.1    Yan, H.J.2    Tsuchiya, N.3
  • 23
    • 84877816058 scopus 로고    scopus 로고
    • Urinary metabolic biomarker and pathway study of hepatitis B virus infected patients based on UPLC-MS system
    • Zhang A, Sun H, Han Y, et al. Urinary metabolic biomarker and pathway study of hepatitis B virus infected patients based on UPLC-MS system. PLoS One 2013;8:e64381.
    • (2013) PLoS One , vol.8 , pp. e64381
    • Zhang, A.1    Sun, H.2    Han, Y.3
  • 24
    • 77950663994 scopus 로고    scopus 로고
    • 1H NMR spectroscopy combined with principal component analysis for metabonomic study on serum of HBV patients
    • 1H NMR spectroscopy combined with principal component analysis for metabonomic study on serum of HBV patients. Acad J Second Military Med University 2010;31: 288-91.
    • (2010) Acad J Second Military Med University , vol.31 , pp. 288-291
    • Yang, Y.1    Yang, S.2    Liang, M.3    Qiu, C.4
  • 25
    • 84911888211 scopus 로고    scopus 로고
    • UNAIDS World AIDS day report 2011. Geneva: UNAIDS [last accessed 10 Jul 2014]
    • UNAIDS World AIDS day report 2011. Geneva: UNAIDS. Available from: http://www.unaids.org/en/media/unaids/contentas sets/documents/unaidspublication/2011/jc2216-worldaidsday- report-2011-en.pdf [last accessed 10 Jul 2014].
  • 26
    • 33646831110 scopus 로고    scopus 로고
    • Applying biofluid 1H NMR-based metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative individuals
    • Hewer R, Vorster J, Steffens FE, Meyer D. Applying biofluid 1H NMR-based metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative individuals. J Pharm Biomed Anal 2006;41:1442-6.
    • (2006) J Pharm Biomed Anal , vol.41 , pp. 1442-1446
    • Hewer, R.1    Vorster, J.2    Steffens, F.E.3    Meyer, D.4
  • 27
    • 67649408723 scopus 로고    scopus 로고
    • Comparative 1H NMR-based metabonomic analysis of HIV-1 sera
    • Philippeos C, Steffens FE, Meyer D. Comparative 1H NMR-based metabonomic analysis of HIV-1 sera. J Biomol NMR 2009;44: 127-37.
    • (2009) J Biomol NMR , vol.44 , pp. 127-137
    • Philippeos, C.1    Steffens, F.E.2    Meyer, D.3
  • 28
    • 79953696557 scopus 로고    scopus 로고
    • Statistical integration of 1H NMR and MRS data from different biofluids and tissues enhances recovery of biological information from individuals with HIV-1 infection
    • Maher D, Cysique LA, Brew BJ, Rae CD. Statistical integration of 1H NMR and MRS data from different biofluids and tissues enhances recovery of biological information from individuals with HIV-1 infection. J Proteome Res 2011;10:1737-45.
    • (2011) J Proteome Res , vol.10 , pp. 1737-1745
    • Maher, D.1    Cysique, L.A.2    Brew, B.J.3    Rae, C.D.4
  • 29
    • 84877824090 scopus 로고    scopus 로고
    • Nuclear magnetic resonance based profiling of biofluids reveals metabolic dysregula-tion in HIV-infected persons and those on antiretroviral therapy
    • Munshi SU, Rewari BB, Bhavesh NS, Jameel S. Nuclear magnetic resonance based profiling of biofluids reveals metabolic dysregula-tion in HIV-infected persons and those on antiretroviral therapy. PLoS One 2013;8:e64298.
    • (2013) PLoS One , vol.8 , pp. e64298
    • Munshi, S.U.1    Rewari, B.B.2    Bhavesh, N.S.3    Jameel, S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.